cambridge-clinical-research-covid

COV-BOOST national vaccination trial at Addenbrooke’s

A team from Cambridge is inviting individuals aged 18 to 30 years…

World-first trial to transfuse lab-grown blood is underway in Cambridge 

Red blood cells that have been grown in a laboratory have been transfused into another person at the NIHR Cambridge Clinical Research Facility (CRF) in a world-first clinical trial.

Red4Research 2022

The #Red4Research concept is simple. Wear…

COV-BOOST national vaccination trial at Addenbrooke’s

A team from Cambridge is inviting individuals aged 18 to 30 years…

Take Part in Research: Our participants share their stories

This International Clinical Trials Day, patients and volunteers and research staff share with us what taking part in research means to them.
Nurse administering a lumbar puncture

CCRC L5 Research Sister Joanne

To celebrate international nurses day we spoke to Joanne, Clinical…

International Nurses’ Day 2022

International Nurses Day is celebrated around the world every…

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows study run in East of England

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide study supported by NIHR Cambridge CRF.

Nationwide NHS trial of artificial pancreas developed in Cambridge

The NIHR Cambridge CRF has delivered over 30 separate studies to support the development of an artificial pancreas, which is now being included in a nationwide trial in the NHS.